These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 27355626)

  • 41. HIV drug resistance tendencies in Latvia.
    Kolupajeva T; Aldins P; Guseva L; Dusacka D; Sondore V; Viksna L; Rozentale B
    Cent Eur J Public Health; 2008 Sep; 16(3):138-40. PubMed ID: 18935781
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Short communication: Prevalence of HIV-1 transmitted drug resistance in Liberia.
    Loubet P; Charpentier C; Visseaux B; Nuta C; Adu E; Chapplain JM; Baysah M; Walters-Doe S; Tattevin P; Peytavin G; Yazdanpanah Y; Descamps D
    AIDS Res Hum Retroviruses; 2014 Sep; 30(9):863-6. PubMed ID: 24946849
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Treatment-naive individuals are the major source of transmitted HIV-1 drug resistance in men who have sex with men in the Swiss HIV Cohort Study.
    Drescher SM; von Wyl V; Yang WL; Böni J; Yerly S; Shah C; Aubert V; Klimkait T; Taffé P; Furrer H; Battegay M; Ambrosioni J; Cavassini M; Bernasconi E; Vernazza PL; Ledergerber B; Günthard HF; Kouyos RD;
    Clin Infect Dis; 2014 Jan; 58(2):285-94. PubMed ID: 24145874
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Short communication: HIV type 1 transmitted drug resistance and evidence of transmission clusters among recently infected antiretroviral-naive individuals from Ugandan fishing communities of Lake Victoria.
    Nazziwa J; Njai HF; Ndembi N; Birungi J; Lyagoba F; Gershim A; Nakiyingi-Miiro J; Nielsen L; Mpendo J; Nanvubya A; Debont J; Grosskurth H; Kamali A; Seeley J; Kaleebu P;
    AIDS Res Hum Retroviruses; 2013 May; 29(5):788-95. PubMed ID: 23173702
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Potential role of doravirine for the treatment of HIV-1-infected persons with transmitted drug resistance.
    Rhee SY; Schapiro JM; Saladini F; Zazzi M; Khoo S; Shafer RW
    AIDS Res Ther; 2023 Feb; 20(1):8. PubMed ID: 36750835
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Trends in the Molecular Epidemiology and Genetic Mechanisms of Transmitted Human Immunodeficiency Virus Type 1 Drug Resistance in a Large US Clinic Population.
    Rhee SY; Clutter D; Fessel WJ; Klein D; Slome S; Pinsky BA; Marcus JL; Hurley L; Silverberg MJ; Kosakovsky Pond SL; Shafer RW
    Clin Infect Dis; 2019 Jan; 68(2):213-221. PubMed ID: 29846534
    [TBL] [Abstract][Full Text] [Related]  

  • 47. High Detection Rate of HIV Drug Resistance Mutations among Patients Who Fail Combined Antiretroviral Therapy in Manaus, Brazil.
    Chaves YO; Pereira FR; de Souza Pinheiro R; Batista DRL; da Silva Balieiro AA; de Lacerda MVG; Nogueira PA; Guimarães ML
    Biomed Res Int; 2021; 2021():5567332. PubMed ID: 34212033
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Trends in HIV-1 pretreatment drug resistance and HIV-1 variant dynamics among antiretroviral therapy-naive Ethiopians from 2003 to 2018: a pooled sequence analysis.
    Kiros M; Biset S; Gebremariam B; Yalew GT; Abegaz WE; Geteneh A
    Virol J; 2023 Oct; 20(1):243. PubMed ID: 37880705
    [TBL] [Abstract][Full Text] [Related]  

  • 49. HIV-1 subtypes and drug resistance in children during antiretroviral therapy in Brazil.
    de Andrade Arrais CR; Lima K; Barreiros M; Rodrigues JKF; Sousa NPS; Costa DD; Santos FDRP; Pereira GFM; E Silva Viana AI; Barros AK; Leal É
    J Med Virol; 2021 Aug; 93(8):4908-4914. PubMed ID: 33788308
    [TBL] [Abstract][Full Text] [Related]  

  • 50. HIV-1 Transmitted Drug Resistance Mutations in Newly Diagnosed Antiretroviral-Naive Patients in Turkey.
    Sayan M; Sargin F; Inan D; Sevgi DY; Celikbas AK; Yasar K; Kaptan F; Kutlu S; Fisgin NT; Inci A; Ceran N; Karaoglan I; Cagatay A; Celen MK; Koruk ST; Ceylan B; Yildirmak T; Akalın H; Korten V; Willke A
    AIDS Res Hum Retroviruses; 2016 Jan; 32(1):26-31. PubMed ID: 26414663
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Increase in transmitted drug resistance in migrants from sub-Saharan Africa diagnosed with HIV-1 in Sweden.
    Andersson E; Nordquist A; Esbjörnsson J; Flamholc L; Gisslén M; Hejdeman B; Marrone G; Norrgren H; Svedhem V; Wendahl S; Albert J; Sönnerborg A
    AIDS; 2018 Apr; 32(7):877-884. PubMed ID: 29369826
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Epidemiological surveillance of HIV-1 transmitted drug resistance among newly diagnosed individuals in Shijiazhuang, northern China, 2014-2015.
    Wang X; Liu X; Li F; Zhou H; Li J; Wang Y; Liu L; Liu S; Feng Y; Wang N
    PLoS One; 2018; 13(6):e0198005. PubMed ID: 29870534
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Increasing HIV-1 Drug Resistance Between 2010 and 2012 in Adults Participating in Population-Based HIV Surveillance in Rural KwaZulu-Natal, South Africa.
    Manasa J; Danaviah S; Lessells R; Elshareef M; Tanser F; Wilkinson E; Pillay S; Mthiyane H; Mwambi H; Pillay D; de Oliveira T
    AIDS Res Hum Retroviruses; 2016 Aug; 32(8):763-9. PubMed ID: 27002368
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Antiretroviral drug resistance in HIV-1 therapy-naive patients in Cuba.
    Pérez L; Kourí V; Alemán Y; Abrahantes Y; Correa C; Aragonés C; Martínez O; Pérez J; Fonseca C; Campos J; Álvarez D; Schrooten Y; Dekeersmaeker N; Imbrechts S; Beheydt G; Vinken L; Soto Y; Álvarez A; Vandamme AM; Van Laethem K
    Infect Genet Evol; 2013 Jun; 16():144-50. PubMed ID: 23416260
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Transmitted drug resistance and transmission clusters among ART-naïve HIV-1-infected individuals from 2019 to 2021 in Nanjing, China.
    Xu Y; Shi H; Dong X; Ding C; Wu S; Li X; Zhang H; Qiao M; Li X; Zhu Z
    Front Public Health; 2023; 11():1179568. PubMed ID: 37674678
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Low prevalence of transmitted HIV type 1 drug resistance among antiretroviral-naive adults in a rural HIV clinic in Kenya.
    Hassan AS; Mwaringa SM; Obonyo CA; Nabwera HM; Sanders EJ; Rinke de Wit TF; Cane PA; Berkley JA
    AIDS Res Hum Retroviruses; 2013 Jan; 29(1):129-35. PubMed ID: 22900472
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Resistance rates among antiretroviral regimens in pregnant people living with HIV.
    da Silveira Gouvêa MIF; de Lourdes Benamor Teixeira M; Fuller T; Sodré MCMP; Medeiros AF; de Mattos Salgueiro M; da Silveira Bressan C; Braga CM; da Silva PA; Mendes-Silva W; Moreira C; Jundi F; Cruz ML; Ceci L; Lattanzi FP; João EC
    HIV Med; 2023 Sep; 24(9):1020-1025. PubMed ID: 37143179
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prevalence of Transmitted HIV Drug Resistance Among Recently Infected Persons in San Diego, CA 1996-2013.
    Panichsillapakit T; Smith DM; Wertheim JO; Richman DD; Little SJ; Mehta SR
    J Acquir Immune Defic Syndr; 2016 Feb; 71(2):228-36. PubMed ID: 26413846
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Transmitted drug resistance mutations and trends of HIV-1 subtypes in treatment-naïve patients: A single-centre experience.
    Mazzuti L; Melengu T; Falasca F; Calabretto M; Cella E; Ciccozzi M; Mezzaroma I; Iaiani G; Spaziante M; d'Ettorre G; Fimiani C; Vullo V; Antonelli G; Turriziani O
    J Glob Antimicrob Resist; 2020 Mar; 20():298-303. PubMed ID: 31518723
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Transmitted drug resistance in persons with acute/early HIV-1 in San Francisco, 2002-2009.
    Jain V; Liegler T; Vittinghoff E; Hartogensis W; Bacchetti P; Poole L; Loeb L; Pilcher CD; Grant RM; Deeks SG; Hecht FM
    PLoS One; 2010 Dec; 5(12):e15510. PubMed ID: 21170322
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.